Q32 Bio Inc. (QTTB) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001661998 · SEC filings checked Oct 18, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 5, 2026 | — | $-8.9M | $-0.44 | Filing |
| Mar 31, 2026 | May 5, 2026 | — | $-7.6M | $-0.54 | Filing |
| Dec 31, 2025 | Mar 10, 2026 | — | $57.7M | $4.70 | Filing |
| Sep 30, 2025 | Nov 13, 2025 | — | $-7.4M | $-0.60 | Filing |
| Jun 30, 2025 | Aug 6, 2025 | — | $-9.5M | $-0.78 | Filing |
| Mar 31, 2025 | May 8, 2025 | — | $-11.0M | $-0.90 | Filing |
| Dec 31, 2024 | Mar 11, 2025 | $0 | $-14.2M | $2.63 | Filing |
| Sep 30, 2024 | Nov 7, 2024 | $0 | $-17.6M | $-1.46 | Filing |
What would Q32 Bio Inc. have to report for its valuation to change?
At $7.77, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -26.6% a year, to $0.66. On that path the next quarter needs diluted EPS near $-0.44, against $-0.60 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | -26.6% | -26.6% |
| EPS needed in final year | $0.66 | $0.66 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. QTTB goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.